These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 10974076)

  • 1. Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells.
    Chen X; Danes C; Lowe M; Herliczek TW; Keyomarsi K
    J Natl Cancer Inst; 2000 Sep; 92(17):1403-13. PubMed ID: 10974076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
    Liu J; Li J; Sidell N
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of p21 (CIP1/WAF1/SID1) by estradiol in a breast epithelial cell line transfected with the recombinant estrogen receptor gene: a possible mechanism for a negative regulatory role of estradiol.
    Thomas TJ; Faaland CA; Adhikarakunnathu S; Watkins LF; Thomas T
    Breast Cancer Res Treat; 1998 Jan; 47(2):181-93. PubMed ID: 9497106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J; Kitlen JW; Briand P; Labrie F; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):469-78. PubMed ID: 12732292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
    Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion.
    Cicatiello L; Addeo R; Altucci L; Belsito Petrizzi V; Boccia V; Cancemi M; Germano D; Pacilio C; Salzano S; Bresciani F; Weisz A
    Mol Cell Endocrinol; 2000 Jul; 165(1-2):199-209. PubMed ID: 10940498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells.
    Mandal S; Davie JR
    J Cell Physiol; 2010 Jul; 224(1):28-32. PubMed ID: 20301197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
    Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells.
    Zhang X; Ding L; Kang L; Wang ZY
    PLoS One; 2012; 7(1):e30174. PubMed ID: 22276155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
    Cariou S; Donovan JC; Flanagan WM; Milic A; Bhattacharya N; Slingerland JM
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9042-6. PubMed ID: 10908655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
    Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
    Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression.
    Hong C; Kim HA; Firestone GL; Bjeldanes LF
    Carcinogenesis; 2002 Aug; 23(8):1297-305. PubMed ID: 12151347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.
    Ito T; Kamijo S; Izumi H; Kohno K; Amano J; Ito K
    Breast Cancer Res Treat; 2012 May; 133(1):145-59. PubMed ID: 21863258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells.
    Margueron R; Licznar A; Lazennec G; Vignon F; Cavaillès V
    J Endocrinol; 2003 Oct; 179(1):41-53. PubMed ID: 14529564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells.
    Mukherjee S; Conrad SE
    J Biol Chem; 2005 May; 280(18):17617-25. PubMed ID: 15757889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells.
    Skildum AJ; Mukherjee S; Conrad SE
    J Biol Chem; 2002 Feb; 277(7):5145-52. PubMed ID: 11741909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.